$3.66
-0.02[-0.54%]
At close: Apr 23
$3.66
0[0.00%]
After Hours: 5:15PM EDT
Anavex Life Sciences
(NASDAQ:AVXL)Anavex Life Sciences Stock (NASDAQ:AVXL), Analyst Ratings, Price Targets, Predictions
Anavex Life Sciences Corp has a consensus price target of $29.75, established from looking at the 17 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on January 3, 2024, November 28, 2023, and August 8, 2023. With an average price target of $49.33 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 1247.91% upside for Anavex Life Sciences Corp from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
BTIG
Cantor Fitzgerald
Berenberg
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Anavex Life Sciences
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/03/2024 | AVXL | Buy Now | Anavex Life Sciences | $3.66 | 992.9% | HC Wainwright & Co. | Raghuram Selvaraju | $54 → $40 | Maintains | Buy | Get Alert |
| 11/28/2023 | AVXL | Buy Now | Anavex Life Sciences | $3.66 | 1375.41% | HC Wainwright & Co. | Raghuram Selvaraju | → $54 | Reiterates | Buy → Buy | Get Alert |
| 08/08/2023 | AVXL | Buy Now | Anavex Life Sciences | $3.66 | 1375.41% | HC Wainwright & Co. | Raghuram Selvaraju | → $54 | Reiterates | Buy → Buy | Get Alert |
| 07/20/2023 | AVXL | Buy Now | Anavex Life Sciences | $3.66 | — | HC Wainwright & Co. | Raghuram Selvaraju | — | Reiterates | Buy → Buy | Get Alert |
| 06/29/2023 | AVXL | Buy Now | Anavex Life Sciences | $3.66 | 1375.41% | HC Wainwright & Co. | Raghuram Selvaraju | → $54 | Reiterates | Buy → Buy | Get Alert |
| 05/02/2023 | AVXL | Buy Now | Anavex Life Sciences | $3.66 | 1375.41% | HC Wainwright & Co. | Raghuram Selvaraju | → $54 | Reiterates | → Buy | Get Alert |
| 03/31/2023 | AVXL | Buy Now | Anavex Life Sciences | $3.66 | 1375.41% | HC Wainwright & Co. | Raghuram Selvaraju | $50 → $54 | Maintains | Buy | Get Alert |
| 02/09/2023 | AVXL | Buy Now | Anavex Life Sciences | $3.66 | 665.03% | BTIG | Yun Zhong | $35 → $28 | Maintains | Buy | Get Alert |
| 02/09/2023 | AVXL | Buy Now | Anavex Life Sciences | $3.66 | 1266.12% | HC Wainwright & Co. | Raghuram Selvaraju | → $50 | Reiterates | → Buy | Get Alert |
| 02/06/2023 | AVXL | Buy Now | Anavex Life Sciences | $3.66 | 1266.12% | HC Wainwright & Co. | Raghuram Selvaraju | → $50 | Reiterates | → Buy | Get Alert |
| 01/03/2023 | AVXL | Buy Now | Anavex Life Sciences | $3.66 | 1266.12% | HC Wainwright & Co. | Raghuram Selvaraju | $42 → $50 | Maintains | Buy | Get Alert |
| 12/06/2022 | AVXL | Buy Now | Anavex Life Sciences | $3.66 | 200.55% | Cantor Fitzgerald | Charles Duncan | $16 → $11 | Downgrade | Overweight → Neutral | Get Alert |
| 06/23/2022 | AVXL | Buy Now | Anavex Life Sciences | $3.66 | 992.9% | Berenberg | Caroline Palomeque | → $40 | Initiates | → Buy | Get Alert |
| 02/02/2022 | AVXL | Buy Now | Anavex Life Sciences | $3.66 | 1047.54% | HC Wainwright & Co. | Raghuram Selvaraju | $39 → $42 | Maintains | Buy | Get Alert |
| 09/23/2021 | AVXL | Buy Now | Anavex Life Sciences | $3.66 | 856.28% | BTIG | Yun Zhong | — | Initiates | → Buy | Get Alert |
| 06/28/2021 | AVXL | Buy Now | Anavex Life Sciences | $3.66 | 965.57% | HC Wainwright & Co. | Raghuram Selvaraju | — | Maintains | Buy | Get Alert |
| 06/15/2021 | AVXL | Buy Now | Anavex Life Sciences | $3.66 | 583.06% | HC Wainwright & Co. | Raghuram Selvaraju | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Anavex Life Sciences (AVXL)?
The latest price target for Anavex Life Sciences (NASDAQ: AVXL) was reported by HC Wainwright & Co. on January 3, 2024. The analyst firm set a price target for $40.00 expecting AVXL to rise to within 12 months (a possible 992.90% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Anavex Life Sciences (AVXL)?
The latest analyst rating for Anavex Life Sciences (NASDAQ: AVXL) was provided by HC Wainwright & Co., and Anavex Life Sciences maintained their buy rating.
When was the last upgrade for Anavex Life Sciences (AVXL)?
There is no last upgrade for Anavex Life Sciences.
When was the last downgrade for Anavex Life Sciences (AVXL)?
The last downgrade for Anavex Life Sciences Corp happened on December 6, 2022 when Cantor Fitzgerald changed their price target from $16 to $11 for Anavex Life Sciences Corp.
When is the next analyst rating going to be posted or updated for Anavex Life Sciences (AVXL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Anavex Life Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Anavex Life Sciences was filed on January 3, 2024 so you should expect the next rating to be made available sometime around January 3, 2025.
Is the Analyst Rating Anavex Life Sciences (AVXL) correct?
While ratings are subjective and will change, the latest Anavex Life Sciences (AVXL) rating was a maintained with a price target of $54.00 to $40.00. The current price Anavex Life Sciences (AVXL) is trading at is $3.66, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.